| Year |
Citation |
Score |
| 2023 |
Livneh I, Cohen-Kaplan V, Fabre B, Abramovitch I, Lulu C, Nataraj NB, Lazar I, Ziv T, Yarden Y, Zohar Y, Gottlieb E, Ciechanover A. Regulation of nucleo-cytosolic 26S proteasome translocation by aromatic amino acids via mTOR is essential for cell survival under stress. Molecular Cell. 83: 3333-3346.e5. PMID 37738964 DOI: 10.1016/j.molcel.2023.08.016 |
0.311 |
|
| 2022 |
Drula R, Iluta S, Gulei D, Iuga C, Dima D, Ghiaur G, Buzoianu AD, Ciechanover A, Tomuleasa C. Exploiting the ubiquitin system in myeloid malignancies. From basic research to drug discovery in MDS and AML. Blood Reviews. 100971. PMID 35595613 DOI: 10.1016/j.blre.2022.100971 |
0.392 |
|
| 2021 |
Fu A, Cohen-Kaplan V, Avni N, Livneh I, Ciechanover A. p62-containing, proteolytically active nuclear condensates, increase the efficiency of the ubiquitin-proteasome system. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34385323 DOI: 10.1073/pnas.2107321118 |
0.442 |
|
| 2020 |
Udasin RG, Gottfried Y, Fabre B, Bercovich B, Ziv T, Ciechanover A. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation. Biochemical and Biophysical Research Communications. PMID 32933748 DOI: 10.1016/J.Bbrc.2020.08.098 |
0.352 |
|
| 2020 |
Ziv NE, Ciechanover A. A possible non-proteolytic role of ubiquitin conjugation in alleviating the pathology of Huntingtin's aggregation. Cell Death and Differentiation. PMID 32913226 DOI: 10.1038/S41418-020-00617-7 |
0.316 |
|
| 2020 |
Hakim-Eshed V, Boulos A, Cohen-Rosenzweig C, Yu-Taeger L, Ziv T, Kwon YT, Riess O, Phuc Nguyen HH, Ziv NE, Ciechanover A. Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects. Proceedings of the National Academy of Sciences of the United States of America. PMID 32675242 DOI: 10.1073/Pnas.2007667117 |
0.391 |
|
| 2020 |
Wang X, Bustos MA, Zhang X, Ramos RI, Tan C, Iida Y, Chang SC, Salomon MP, Tran K, Gentry R, Kravtsova-Ivantsiv Y, Kelly DF, Mills GB, Ciechanover A, Mao Y, et al. Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors. Cancers. 12. PMID 32349217 DOI: 10.3390/Cancers12051081 |
0.315 |
|
| 2019 |
Ji CH, Kim HY, Heo AJ, Lee SH, Lee MJ, Kim SB, Srinivasrao G, Mun SR, Cha-Molstad H, Ciechanover A, Choi CY, Lee HG, Kim BY, Kwon YT. The N-Degron Pathway Mediates ER-phagy. Molecular Cell. PMID 31375263 DOI: 10.1016/J.Molcel.2019.06.028 |
0.407 |
|
| 2019 |
Fabre B, Livneh I, Ziv T, Ciechanover A. Identification of proteins regulated by the proteasome following induction of endoplasmic reticulum stress. Biochemical and Biophysical Research Communications. 517: 188-192. PMID 31327494 DOI: 10.1016/J.Bbrc.2019.07.040 |
0.436 |
|
| 2019 |
Nawatha M, Rogers JM, Bonn SM, Livneh I, Lemma B, Mali SM, Vamisetti GB, Sun H, Bercovich B, Huang Y, Ciechanover A, Fushman D, Suga H, Brik A. De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains. Nature Chemistry. PMID 31182821 DOI: 10.1038/S41557-019-0278-X |
0.355 |
|
| 2019 |
Fabre B, Livneh I, Ziv T, Ciechanover A. Modulation of the cell cycle regulating transcription factor E2F1 pathway by the proteasome following amino acid starvation. Biochemical and Biophysical Research Communications. PMID 30992132 DOI: 10.1016/J.Bbrc.2019.04.066 |
0.479 |
|
| 2019 |
Cohen-Kaplan V, Livneh I, Kwon YT, Ciechanover A. Monitoring stress-induced autophagic engulfment and degradation of the 26S proteasome in mammalian cells. Methods in Enzymology. 619: 337-366. PMID 30910028 DOI: 10.1016/Bs.Mie.2018.12.022 |
0.469 |
|
| 2019 |
Sun H, Mali SM, Singh SK, Meledin R, Brik A, Kwon YT, Kravtsova-Ivantsiv Y, Bercovich B, Ciechanover A. Diverse fate of ubiquitin chain moieties: The proximal is degraded with the target, and the distal protects the proximal from removal and recycles. Proceedings of the National Academy of Sciences of the United States of America. PMID 30867293 DOI: 10.1073/Pnas.1822148116 |
0.463 |
|
| 2018 |
Yoo YD, Mun SR, Ji CH, Sung KW, Kang KY, Heo AJ, Lee SH, An JY, Hwang J, Xie XQ, Ciechanover A, Kim BY, Kwon YT. N-terminal arginylation generates a bimodal degron that modulates autophagic proteolysis. Proceedings of the National Academy of Sciences of the United States of America. PMID 29507222 DOI: 10.1073/Pnas.1719110115 |
0.429 |
|
| 2018 |
Shim SM, Choi HR, Sung KW, Lee YJ, Kim ST, Kim D, Mun SR, Hwang J, Cha-Molstad H, Ciechanover A, Kim BY, Kwon YT. The endoplasmic reticulum-residing chaperone BiP is short-lived and metabolized through N-terminal arginylation. Science Signaling. 11. PMID 29295953 DOI: 10.1126/Scisignal.Aan0630 |
0.395 |
|
| 2018 |
Iida Y, Ciechanover A, Marzese DM, Hata K, Bustos M, Ono S, Wang J, Salomon MP, Tran K, Kravtsova-Ivantsiv Y, Mills GB, Davies MA, Hoon DSB. Abstract 3541: Epigenetic regulation of KPC1 ubiquitin ligase has a regulatory role on the NF-κB pathway in metastatic melanoma Cancer Research. 78: 3541-3541. DOI: 10.1158/1538-7445.Am2018-3541 |
0.342 |
|
| 2017 |
Cha-Molstad H, Lee SH, Kim JG, Sung KW, Hwang J, Shim SM, Ganipisetti S, McGuire T, Mook-Jung I, Ciechanover A, Xie XQ, Kim BY, Kwon YT. Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathway. Autophagy. 1-6. PMID 29261001 DOI: 10.1080/15548627.2017.1415190 |
0.377 |
|
| 2017 |
Ciechanover A. Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Best Practice & Research. Clinical Haematology. 30: 341-355. PMID 29156207 DOI: 10.1016/J.Beha.2017.09.001 |
0.489 |
|
| 2017 |
Kwon YT, Ciechanover A. The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy. Trends in Biochemical Sciences. PMID 28947091 DOI: 10.1016/J.Tibs.2017.09.002 |
0.507 |
|
| 2017 |
Cha-Molstad H, Yu JE, Feng Z, Lee SH, Kim JG, Yang P, Han B, Sung KW, Yoo YD, Hwang J, McGuire T, Shim SM, Song HD, Ganipisetti S, Wang N, ... ... Ciechanover A, et al. p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis. Nature Communications. 8: 102. PMID 28740232 DOI: 10.1038/S41467-017-00085-7 |
0.359 |
|
| 2017 |
Livneh I, Kravtsova-Ivantsiv Y, Braten O, Kwon YT, Ciechanover A. Monoubiquitination joins polyubiquitination as an esteemed proteasomal targeting signal. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. PMID 28493408 DOI: 10.1002/Bies.201700027 |
0.488 |
|
| 2017 |
Ciechanover A, Kwon YT. Protein Quality Control by Molecular Chaperones in Neurodegeneration. Frontiers in Neuroscience. 11: 185. PMID 28428740 DOI: 10.3389/Fnins.2017.00185 |
0.447 |
|
| 2017 |
Iida Y, Ciechanover A, Marzese DM, Hata K, Bustos M, Ono S, Wang J, Salomon MP, Tran K, Lam S, Hsu SC, Nelson N, Kravtsova-Ivantsiv Y, Mills GB, Davies MA, et al. Epigenetic Regulation of KPC1 Ubiquitin Ligase Effects the NF-κB Pathway in Melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28389511 DOI: 10.1158/1078-0432.Ccr-17-0146 |
0.33 |
|
| 2017 |
Barac YD, Emrich F, Krutzwakd-Josefson E, Schrepfer S, Sampaio LC, Willerson JT, Robbins RC, Ciechanover A, Mohr FW, Aravot D, Taylor DA. The ubiquitin-proteasome system: A potential therapeutic target for heart failure. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 28341100 DOI: 10.1016/J.Healun.2017.02.012 |
0.324 |
|
| 2017 |
Etzioni A, Ciechanover A, Pikarsky E. Immune defects caused by mutations in the ubiquitin system. The Journal of Allergy and Clinical Immunology. 139: 743-753. PMID 28270366 DOI: 10.1016/J.Jaci.2016.11.031 |
0.301 |
|
| 2017 |
Cohen-Kaplan V, Ciechanover A, Livneh I. Stress-induced polyubiquitination of proteasomal ubiquitin receptors targets the proteolytic complex for autophagic degradation. Autophagy. 0. PMID 28121483 DOI: 10.1080/15548627.2016.1278327 |
0.529 |
|
| 2017 |
Lehmann G, Udasin RG, Livneh I, Ciechanover A. Identification of UBact, a ubiquitin-like protein, along with other homologous components of a conjugation system and the proteasome in different gram-negative bacteria. Biochemical and Biophysical Research Communications. PMID 28087277 DOI: 10.1016/J.Bbrc.2017.01.037 |
0.432 |
|
| 2017 |
Emrich F, Barac Y, Steinbach S, Kellermann K, Dieterlen M, Lehmann S, Noack T, Penov K, Aravot D, Ciechanover A, Mohr F, Garbade J. The Ubiquitin Proteasome System as Potential Therapeutic Target in Dilated and Ischemic Cardiomyopathy The Journal of Heart and Lung Transplantation. 36: S382. DOI: 10.1016/J.Healun.2017.01.1090 |
0.318 |
|
| 2016 |
Yoo YD, Lee DH, Cha-Molstad H, Kim H, Mun SR, Ji C, Park SH, Sung KS, Choi SA, Hwang J, Park DM, Kim SK, Park KJ, Kang SH, Oh SC, ... Ciechanover A, et al. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition. Embo Reports. PMID 27993939 DOI: 10.15252/Embr.201642360 |
0.309 |
|
| 2016 |
Cohen-Kaplan V, Ciechanover A, Livneh I. p62 at the crossroad of the ubiquitin-proteasome system and autophagy. Oncotarget. PMID 27974671 DOI: 10.18632/Oncotarget.13805 |
0.348 |
|
| 2016 |
Lahav-Baratz S, Kravtsova-Ivantsiv Y, Golan S, Ciechanover A. The testis-specific USP26 is a deubiquitinating enzyme of the ubiquitin ligase Mdm2. Biochemical and Biophysical Research Communications. PMID 27810359 DOI: 10.1016/J.Bbrc.2016.10.135 |
0.442 |
|
| 2016 |
Cohen-Kaplan V, Livneh I, Avni N, Fabre B, Ziv T, Kwon YT, Ciechanover A. p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome. Proceedings of the National Academy of Sciences of the United States of America. PMID 27791183 DOI: 10.1073/Pnas.1615455113 |
0.44 |
|
| 2016 |
Cohen-Kaplan V, Livneh I, Avni N, Cohen-Rosenzweig C, Ciechanover A. The ubiquitin-proteasome system and autophagy: Coordinated and independent activities. The International Journal of Biochemistry & Cell Biology. PMID 27448843 DOI: 10.1016/J.Biocel.2016.07.019 |
0.495 |
|
| 2016 |
Livneh I, Cohen-Kaplan V, Cohen-Rosenzweig C, Avni N, Ciechanover A. The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death. Cell Research. 26: 869-85. PMID 27444871 DOI: 10.1038/Cr.2016.86 |
0.466 |
|
| 2016 |
Braten O, Livneh I, Ziv T, Admon A, Kehat I, Caspi LH, Gonen H, Bercovich B, Godzik A, Jahandideh S, Jaroszewski L, Sommer T, Kwon YT, Guharoy M, Tompa P, ... Ciechanover A, et al. Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination. Proceedings of the National Academy of Sciences of the United States of America. PMID 27385826 DOI: 10.1073/Pnas.1608644113 |
0.489 |
|
| 2016 |
Eisenberg-Lerner A, Ciechanover A, Merbl Y. Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer. Experimental Biology and Medicine (Maywood, N.J.). PMID 27229346 DOI: 10.1177/1535370216651732 |
0.468 |
|
| 2016 |
Lehmann G, Ziv T, Braten O, Admon A, Udasin RG, Ciechanover A. Ubiquitination of specific mitochondrial matrix proteins. Biochemical and Biophysical Research Communications. PMID 27157140 DOI: 10.1016/J.Bbrc.2016.04.150 |
0.408 |
|
| 2016 |
Lehmann G, Udasin RG, Ciechanover A. On the linkage between the ubiquitin-proteasome system and the mitochondria. Biochemical and Biophysical Research Communications. PMID 26996128 DOI: 10.1016/J.Bbrc.2016.03.055 |
0.431 |
|
| 2016 |
Mollereau B, Rzechorzek NM, Roussel BD, Sedru M, Van den Brink D, Bailly-Maitre B, Palladino F, Medinas DB, Domingos PM, Hunot S, Chandran S, Birman S, Baron T, Vivien D, Duarte CB, ... ... Ciechanover A, et al. Adaptive Preconditioning in Neurological Diseases - Therapeutic Insights from Proteostatic Perturbations. Brain Research. PMID 26923166 DOI: 10.1016/J.Brainres.2016.02.033 |
0.326 |
|
| 2016 |
Cha-Molstad H, Yu JE, Lee SH, Kim JG, Sung KS, Hwang J, Yoo YD, Lee YJ, Kim ST, Lee DH, Ciechanover A, Kim BY, Kwon YT. Modulation of SQSTM1/p62 activity by N-terminal arginylation of the endoplasmic reticulum chaperone HSPA5/GRP78/BiP. Autophagy. 0. PMID 26797053 DOI: 10.1080/15548627.2015.1126047 |
0.423 |
|
| 2016 |
Kravtsova-Ivantsiv Y, Kwon YT, Ciechanover A. Role of the ubiquitin ligase KPC1 in NF-κB activation and tumor suppression Journal of Analytical Science and Technology. 7. DOI: 10.1186/S40543-016-0087-4 |
0.402 |
|
| 2015 |
Kravtsova-Ivantsiv Y, Ciechanover A. The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression. Molecular & Cellular Oncology. 2: e1054552. PMID 27308511 DOI: 10.1080/23723556.2015.1054552 |
0.331 |
|
| 2015 |
Cha-Molstad H, Sung KS, Hwang J, Kim KA, Yu JE, Yoo YD, Jang JM, Han DH, Molstad M, Kim JG, Lee YJ, Zakrzewska A, Kim SH, Kim ST, Kim SY, ... ... Ciechanover A, et al. Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding. Nature Cell Biology. 17: 917-29. PMID 26075355 DOI: 10.1038/Ncb3177 |
0.373 |
|
| 2015 |
Ciechanover A. The unravelling of the ubiquitin system. Nature Reviews. Molecular Cell Biology. 16: 322-4. PMID 25907614 DOI: 10.1038/Nrm3982 |
0.378 |
|
| 2015 |
Kravtsova-Ivantsiv Y, Shomer I, Cohen-Kaplan V, Snijder B, Superti-Furga G, Gonen H, Sommer T, Ziv T, Admon A, Naroditsky I, Jbara M, Brik A, Pikarsky E, Kwon YT, Doweck I, ... Ciechanover A, et al. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth. Cell. 161: 333-47. PMID 25860612 DOI: 10.1016/J.Cell.2015.03.001 |
0.343 |
|
| 2015 |
Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Experimental & Molecular Medicine. 47: e147. PMID 25766616 DOI: 10.1038/Emm.2014.117 |
0.454 |
|
| 2015 |
Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, ... ... Ciechanover A, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death and Differentiation. 22: 58-73. PMID 25236395 DOI: 10.1038/Cdd.2014.137 |
0.317 |
|
| 2014 |
Ahmed Q, Avidan AY, Ciechanover A, Shechtman D, Zajfman D, Reichman U, Kornberg R, Hershko A, Lavie P. Israel-Gaza conflict. Lancet (London, England). 384: e34-7. PMID 25145777 DOI: 10.1016/S0140-6736(14)61314-3 |
0.434 |
|
| 2014 |
Rossi M, Rotblat B, Ansell K, Amelio I, Caraglia M, Misso G, Bernassola F, Cavasotto CN, Knight RA, Ciechanover A, Melino G. High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. Cell Death & Disease. 5: e1203. PMID 24787015 DOI: 10.1038/Cddis.2014.113 |
0.359 |
|
| 2014 |
Belogurov A, Kudriaeva A, Kuzina E, Smirnov I, Bobik T, Ponomarenko N, Kravtsova-Ivantsiv Y, Ciechanover A, Gabibov A. Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradation. The Journal of Biological Chemistry. 289: 17758-66. PMID 24739384 DOI: 10.1074/Jbc.M113.544247 |
0.474 |
|
| 2014 |
Hemantha HP, Bavikar SN, Herman-Bachinsky Y, Haj-Yahya N, Bondalapati S, Ciechanover A, Brik A. Nonenzymatic polyubiquitination of expressed proteins. Journal of the American Chemical Society. 136: 2665-73. PMID 24437386 DOI: 10.1021/Ja412594D |
0.516 |
|
| 2014 |
Ciechanover A, Stanhill A. The complexity of recognition of ubiquitinated substrates by the 26S proteasome. Biochimica Et Biophysica Acta. 1843: 86-96. PMID 23872423 DOI: 10.1016/J.Bbamcr.2013.07.007 |
0.522 |
|
| 2013 |
Haj-Yahya M, Fauvet B, Herman-Bachinsky Y, Hejjaoui M, Bavikar SN, Karthikeyan SV, Ciechanover A, Lashuel HA, Brik A. Synthetic polyubiquitinated α-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology. Proceedings of the National Academy of Sciences of the United States of America. 110: 17726-31. PMID 24043770 DOI: 10.1073/Pnas.1315654110 |
0.41 |
|
| 2013 |
Haj-Yahya N, Haj-Yahya M, Castañeda CA, Spasser L, Hemantha HP, Jbara M, Penner M, Ciechanover A, Fushman D, Brik A. Modifying the vicinity of the isopeptide bond to reveal differential behavior of ubiquitin chains with interacting proteins: organic chemistry applied to synthetic proteins. Angewandte Chemie (International Ed. in English). 52: 11149-53. PMID 24006204 DOI: 10.1002/Anie.201306118 |
0.409 |
|
| 2013 |
Bagola K, von Delbrück M, Dittmar G, Scheffner M, Ziv I, Glickman MH, Ciechanover A, Sommer T. Ubiquitin binding by a CUE domain regulates ubiquitin chain formation by ERAD E3 ligases. Molecular Cell. 50: 528-39. PMID 23665229 DOI: 10.1016/J.Molcel.2013.04.005 |
0.424 |
|
| 2013 |
Ciechanover A. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Bioorganic & Medicinal Chemistry. 21: 3400-10. PMID 23485445 DOI: 10.1016/J.Bmc.2013.01.056 |
0.489 |
|
| 2013 |
Kravtsova-Ivantsiv Y, Sommer T, Ciechanover A. The lysine48-based polyubiquitin chain proteasomal signal: not a single child anymore. Angewandte Chemie (International Ed. in English). 52: 192-8. PMID 23124625 DOI: 10.1002/Anie.201205656 |
0.46 |
|
| 2012 |
Ciechanover A. Intracellular Protein Degradation: From a Vague Idea through the Lysosome and the Ubiquitin-Proteasome System and onto Human Diseases and Drug Targeting. Rambam Maimonides Medical Journal. 3: e0001. PMID 23908826 DOI: 10.5041/Rmmj.10068 |
0.489 |
|
| 2012 |
Buchsbaum S, Bercovich B, Ziv T, Ciechanover A. Modification of the inflammatory mediator LRRFIP2 by the ubiquitin-like protein FAT10 inhibits its activity during cellular response to LPS. Biochemical and Biophysical Research Communications. 428: 11-6. PMID 23036196 DOI: 10.1016/J.Bbrc.2012.09.110 |
0.459 |
|
| 2012 |
Ciechanover A, Hod Y, Hershko A. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. 1978. Biochemical and Biophysical Research Communications. 425: 565-70. PMID 22925675 DOI: 10.1016/J.Bbrc.2012.08.025 |
0.548 |
|
| 2012 |
de Bie P, Ciechanover A. RING1B ubiquitination and stability are regulated by ARF. Biochemical and Biophysical Research Communications. 426: 49-53. PMID 22910419 DOI: 10.1016/J.Bbrc.2012.08.030 |
0.394 |
|
| 2012 |
Shabek N, Herman-Bachinsky Y, Buchsbaum S, Lewinson O, Haj-Yahya M, Hejjaoui M, Lashuel HA, Sommer T, Brik A, Ciechanover A. The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation. Molecular Cell. 48: 87-97. PMID 22902562 DOI: 10.1016/J.Molcel.2012.07.011 |
0.772 |
|
| 2012 |
Braten O, Shabek N, Kravtsova-Ivantsiv Y, Ciechanover A. Generation of free ubiquitin chains is up-regulated in stress and facilitated by the HECT domain ubiquitin ligases UFD4 and HUL5. The Biochemical Journal. 444: 611-7. PMID 22497224 DOI: 10.1042/Bj20111840 |
0.745 |
|
| 2012 |
Kravtsova-Ivantsiv Y, Ciechanover A. Non-canonical ubiquitin-based signals for proteasomal degradation. Journal of Cell Science. 125: 539-48. PMID 22389393 DOI: 10.1242/Jcs.093567 |
0.523 |
|
| 2012 |
Craxton A, Butterworth M, Harper N, Fairall L, Schwabe J, Ciechanover A, Cohen GM. NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1. Cell Death and Differentiation. 19: 1424-34. PMID 22361683 DOI: 10.1038/Cdd.2012.16 |
0.493 |
|
| 2012 |
Ciechanover A. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Neuro-Degenerative Diseases. 10: 7-22. PMID 22327508 DOI: 10.1159/000334283 |
0.488 |
|
| 2012 |
Noy T, Suad O, Taglicht D, Ciechanover A. HUWE1 ubiquitinates MyoD and targets it for proteasomal degradation. Biochemical and Biophysical Research Communications. 418: 408-13. PMID 22277673 DOI: 10.1016/J.Bbrc.2012.01.045 |
0.473 |
|
| 2012 |
Buchsbaum S, Bercovich B, Ciechanover A. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination. Molecular Biology of the Cell. 23: 225-32. PMID 22072791 DOI: 10.1091/Mbc.E11-07-0609 |
0.51 |
|
| 2012 |
Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Biochimica Et Biophysica Acta. 1824: 3-13. PMID 21435401 DOI: 10.1016/J.Bbapap.2011.03.007 |
0.488 |
|
| 2012 |
Kravtsova-Ivantsiv Y, Sommer T, Ciechanover A. Die Lys48-verknüpfte Polyubiquitinkette als proteasomales Signal: kein Einzelkind mehr Angewandte Chemie. 125: 202-209. DOI: 10.1002/Ange.201205656 |
0.314 |
|
| 2011 |
Nguyen LK, Muñoz-García J, Maccario H, Ciechanover A, Kolch W, Kholodenko BN. Switches, excitable responses and oscillations in the Ring1B/Bmi1 ubiquitination system. Plos Computational Biology. 7: e1002317. PMID 22194680 DOI: 10.1371/Journal.Pcbi.1002317 |
0.35 |
|
| 2011 |
Ciechanover A. On the wings of imagination. Nature. 478: S4. PMID 21993824 DOI: 10.1038/478S4A |
0.384 |
|
| 2011 |
Weissman AM, Shabek N, Ciechanover A. The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nature Reviews. Molecular Cell Biology. 12: 605-20. PMID 21860393 DOI: 10.1038/Nrm3173 |
0.768 |
|
| 2011 |
Kravtsova-Ivantsiv Y, Ciechanover A. Ubiquitination and degradation of proteins. Methods in Molecular Biology (Clifton, N.J.). 753: 335-57. PMID 21604134 DOI: 10.1007/978-1-61779-148-2_23 |
0.484 |
|
| 2011 |
Zoabi M, Sadeh R, de Bie P, Marquez VE, Ciechanover A. PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins. Biochemical and Biophysical Research Communications. 408: 393-8. PMID 21513699 DOI: 10.1016/J.Bbrc.2011.04.025 |
0.458 |
|
| 2011 |
Kühnle S, Kogel U, Glockzin S, Marquardt A, Ciechanover A, Matentzoglu K, Scheffner M. Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2. The Journal of Biological Chemistry. 286: 19410-6. PMID 21493713 DOI: 10.1074/Jbc.M110.205211 |
0.495 |
|
| 2011 |
de Bie P, Ciechanover A. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms. Cell Death and Differentiation. 18: 1393-402. PMID 21372847 DOI: 10.1038/Cdd.2011.16 |
0.454 |
|
| 2011 |
Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, Eppink B, Chung YM, Shalev G, Shema E, Shkedy D, Smorodinsky NI, van Vliet N, Kuster B, Mann M, ... Ciechanover A, et al. Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Molecular Cell. 41: 529-42. PMID 21362549 DOI: 10.1016/J.Molcel.2011.02.015 |
0.309 |
|
| 2011 |
Kravtsova-Ivantsiv Y, Cohen S, Ciechanover A. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-κB precursor. Advances in Experimental Medicine and Biology. 691: 95-106. PMID 21153313 DOI: 10.1007/978-1-4419-6612-4_10 |
0.335 |
|
| 2011 |
Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Szekely L, Bercovich B, Ciechanover A, Klein G. Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53. International Journal of Cancer. Journal International Du Cancer. 128: 817-25. PMID 20473904 DOI: 10.1002/Ijc.25414 |
0.309 |
|
| 2011 |
Weissman AM, Shabek N, Ciechanover A. Erratum: The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation Nature Reviews Molecular Cell Biology. 12: 686-686. DOI: 10.1038/Nrm3191 |
0.746 |
|
| 2011 |
Zoabi M, Sadeh R, de Bie P, Marquez VE, Ciechanover A. Corrigendum to "PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins" [Biochem. Biophys. Res. Commun. 408 (2011) 393-398] Biochemical and Biophysical Research Communications. 410: 705. DOI: 10.1016/J.Bbrc.2011.06.037 |
0.381 |
|
| 2010 |
de Bie P, Zaaroor-Regev D, Ciechanover A. Regulation of the Polycomb protein RING1B ubiquitination by USP7. Biochemical and Biophysical Research Communications. 400: 389-95. PMID 20800574 DOI: 10.1016/J.Bbrc.2010.08.082 |
0.453 |
|
| 2010 |
Zaaroor-Regev D, de Bie P, Scheffner M, Noy T, Shemer R, Heled M, Stein I, Pikarsky E, Ciechanover A. Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome. Proceedings of the National Academy of Sciences of the United States of America. 107: 6788-93. PMID 20351251 DOI: 10.1073/Pnas.1003108107 |
0.408 |
|
| 2010 |
Shabek N, Ciechanover A. Degradation of ubiquitin: the fate of the cellular reaper. Cell Cycle (Georgetown, Tex.). 9: 523-30. PMID 20107325 DOI: 10.4161/Cc.9.3.11152 |
0.793 |
|
| 2010 |
Bernassola F, Ciechanover A, Melino G. The ubiquitin proteasome system and its involvement in cell death pathways. Cell Death and Differentiation. 17: 1-3. PMID 20010850 DOI: 10.1038/Cdd.2009.189 |
0.361 |
|
| 2010 |
Kornitzer D, Ciechanover A. Ubiquitination/proteasome Handbook of Cell Signaling, 2/E. 3: 2093-2098. DOI: 10.1016/B978-0-12-374145-5.00255-2 |
0.345 |
|
| 2009 |
Navon A, Ciechanover A. The 26 S proteasome: from basic mechanisms to drug targeting. The Journal of Biological Chemistry. 284: 33713-8. PMID 19812037 DOI: 10.1074/Jbc.R109.018481 |
0.51 |
|
| 2009 |
Cohen S, Ciechanover A, Kravtsova-Ivantsiv Y, Lapid D, Lahav-Baratz S. ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor. Biochemical and Biophysical Research Communications. 389: 205-10. PMID 19695220 DOI: 10.1016/J.Bbrc.2009.08.074 |
0.336 |
|
| 2009 |
Shabek N, Herman-Bachinsky Y, Ciechanover A. Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proceedings of the National Academy of Sciences of the United States of America. 106: 11907-12. PMID 19581590 DOI: 10.1073/Pnas.0905746106 |
0.78 |
|
| 2009 |
Ciechanover A. The 2008 Lindau Nobel Laureate Meeting: Aaron Ciechanover, Chemistry 2004. Journal of Visualized Experiments : Jove. PMID 19571788 DOI: 10.3791/1559 |
0.369 |
|
| 2009 |
Ciechanover A. Tracing the history of the ubiquitin proteolytic system: the pioneering article. Biochemical and Biophysical Research Communications. 387: 1-10. PMID 19539608 DOI: 10.1016/J.Bbrc.2009.06.065 |
0.422 |
|
| 2009 |
Kravtsova-Ivantsiv Y, Cohen S, Ciechanover A. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor. Molecular Cell. 33: 496-504. PMID 19250910 DOI: 10.1016/J.Molcel.2009.01.023 |
0.418 |
|
| 2009 |
Schwartz AL, Ciechanover A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annual Review of Pharmacology and Toxicology. 49: 73-96. PMID 18834306 DOI: 10.1146/Annurev.Pharmtox.051208.165340 |
0.477 |
|
| 2008 |
Sadeh R, Breitschopf K, Bercovich B, Zoabi M, Kravtsova-Ivantsiv Y, Kornitzer D, Schwartz A, Ciechanover A. The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system. Proceedings of the National Academy of Sciences of the United States of America. 105: 15690-5. PMID 18836078 DOI: 10.1073/Pnas.0808373105 |
0.465 |
|
| 2008 |
Jaitovich A, Mehta S, Na N, Ciechanover A, Goldman RD, Ridge KM. Ubiquitin-proteasome-mediated degradation of keratin intermediate filaments in mechanically stimulated A549 cells. The Journal of Biological Chemistry. 283: 25348-55. PMID 18617517 DOI: 10.1074/Jbc.M801635200 |
0.38 |
|
| 2008 |
Bernassola F, Karin M, Ciechanover A, Melino G. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell. 14: 10-21. PMID 18598940 DOI: 10.1016/J.Ccr.2008.06.001 |
0.377 |
|
| 2008 |
Melino G, Gallagher E, Aqeilan RI, Knight R, Peschiaroli A, Rossi M, Scialpi F, Malatesta M, Zocchi L, Browne G, Ciechanover A, Bernassola F. Itch: a HECT-type E3 ligase regulating immunity, skin and cancer. Cell Death and Differentiation. 15: 1103-12. PMID 18552861 DOI: 10.1038/Cdd.2008.60 |
0.36 |
|
| 2008 |
Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL. In vivo interactions of MyoD, Id1, and E2A proteins determined by acceptor photobleaching fluorescence resonance energy transfer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 1694-701. PMID 18198216 DOI: 10.1096/Fj.07-095000 |
0.456 |
|
| 2008 |
Mayer RJ, Ciechanover AJ, Rechsteiner M. Protein Degradation Protein Degradation. 2: 1-286. DOI: 10.1002/9783527620210 |
0.351 |
|
| 2007 |
Ciechanover A. Intracellular protein degradation from a vague idea through the lysosome and the ubiquitin-proteasome system and on to human diseases and drug targeting: Nobel Lecture, December 8, 2004. Annals of the New York Academy of Sciences. 1116: 1-28. PMID 18083918 DOI: 10.1196/Annals.1402.078 |
0.496 |
|
| 2007 |
Shabek N, Iwai K, Ciechanover A. Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target. Biochemical and Biophysical Research Communications. 363: 425-31. PMID 17870054 DOI: 10.1016/J.Bbrc.2007.08.185 |
0.776 |
|
| 2007 |
Herman-Bachinsky Y, Ryoo HD, Ciechanover A, Gonen H. Regulation of the Drosophila ubiquitin ligase DIAP1 is mediated via several distinct ubiquitin system pathways. Cell Death and Differentiation. 14: 861-71. PMID 17205079 DOI: 10.1038/sj.cdd.4402079 |
0.38 |
|
| 2007 |
Sun L, Trausch-Azar JS, Ciechanover A, Schwartz AL. E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation. Oncogene. 26: 441-8. PMID 16909127 DOI: 10.1038/Sj.Onc.1209793 |
0.436 |
|
| 2007 |
Mayer RJ, Ciechanover AJ, Rechsteiner M. Protein Degradation: Cell Biology of the Ubiquitin-Proteasome System, Volume 3 Protein Degradation: Cell Biology of the Ubiquitin-Proteasome System, Volume 3. 1-238. DOI: 10.1002/9783527620227 |
0.371 |
|
| 2006 |
Ben-Saadon R, Zaaroor D, Ziv T, Ciechanover A. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Molecular Cell. 24: 701-11. PMID 17157253 DOI: 10.1016/J.Molcel.2006.10.022 |
0.415 |
|
| 2006 |
Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 1-12, 505-6. PMID 17124032 DOI: 10.1182/Asheducation-2006.1.1 |
0.489 |
|
| 2006 |
Reinstein E, Ciechanover A. Narrative review: protein degradation and human diseases: the ubiquitin connection. Annals of Internal Medicine. 145: 676-84. PMID 17088581 DOI: 10.7326/0003-4819-145-9-200611070-00010 |
0.468 |
|
| 2006 |
Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Experimental Biology and Medicine (Maywood, N.J.). 231: 1197-211. PMID 16816126 DOI: 10.1177/153537020623100705 |
0.481 |
|
| 2006 |
Cohen S, Lahav-Baratz S, Ciechanover A. Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis. Biochemical and Biophysical Research Communications. 345: 7-13. PMID 16678126 DOI: 10.1016/J.Bbrc.2006.04.036 |
0.415 |
|
| 2006 |
Ciechanover A. The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting. Neurology. 66: S7-19. PMID 16432150 DOI: 10.1212/01.Wnl.0000192261.02023.B8 |
0.544 |
|
| 2006 |
Glickman MH, Ciechanover A. Ubiquitin-Proteasome System for Controlling Cellular Protein Levels Reviews in Cell Biology and Molecular Medicine. DOI: 10.1002/3527600906.Mcb.200400161 |
0.56 |
|
| 2005 |
Ciechanover A. Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture). Angewandte Chemie (International Ed. in English). 44: 5944-67. PMID 16142822 DOI: 10.1002/Anie.200501428 |
0.489 |
|
| 2005 |
Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Cell Death and Differentiation. 12: 1178-90. PMID 16094394 DOI: 10.1038/Sj.Cdd.4401692 |
0.481 |
|
| 2005 |
Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system--micro target for macro intervention? International Journal of Cardiovascular Interventions. 7: 5-13. PMID 16019609 DOI: 10.1080/14628840510011234 |
0.427 |
|
| 2005 |
Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL. E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1. Oncogene. 24: 6376-84. PMID 16007194 DOI: 10.1038/Sj.Onc.1208789 |
0.364 |
|
| 2005 |
Ciechanover A. N-terminal ubiquitination. Methods in Molecular Biology (Clifton, N.J.). 301: 255-70. PMID 15917637 DOI: 10.1385/1-59259-895-1:255 |
0.448 |
|
| 2005 |
Sun L, Trausch-Azar JS, Ciechanover A, Schwartz AL. Ubiquitin-proteasome-mediated degradation, intracellular localization, and protein synthesis of MyoD and Id1 during muscle differentiation. The Journal of Biological Chemistry. 280: 26448-56. PMID 15888449 DOI: 10.1074/Jbc.M500373200 |
0.43 |
|
| 2005 |
Lotan R, Rotem A, Gonen H, Finberg JP, Kemeny S, Steller H, Ciechanover A, Larisch S. Regulation of the proapoptotic ARTS protein by ubiquitin-mediated degradation. The Journal of Biological Chemistry. 280: 25802-10. PMID 15837787 DOI: 10.1074/Jbc.M501955200 |
0.381 |
|
| 2005 |
Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nature Reviews. Molecular Cell Biology. 6: 79-87. PMID 15688069 DOI: 10.1038/Nrm1552 |
0.487 |
|
| 2005 |
Ciechanover A. Intrazellulärer Proteinabbau: von einer ungenauen Vorstellung vom Lysosom und Ubiquitin-Proteasom- System bis hin zu menschlichen Krankheiten und zum Wirkstoff-Targeting (Nobel-Vortrag) Angewandte Chemie. 117: 6095-6119. DOI: 10.1002/Ange.200501428 |
0.405 |
|
| 2005 |
Mayer RJ, Ciechanover A, Rechsteiner M. Protein Degradation: Ubiquitin and the Chemistry of Life Protein Degradation: Ubiquitin and the Chemistry of Life. 1: 1-377. DOI: 10.1002/352760586X |
0.315 |
|
| 2004 |
Ciechanover A, Schwartz AL. The ubiquitin system: pathogenesis of human diseases and drug targeting. Biochimica Et Biophysica Acta. 1695: 3-17. PMID 15571805 DOI: 10.1016/J.Bbamcr.2004.09.018 |
0.479 |
|
| 2004 |
Ben-Saadon R, Fajerman I, Ziv T, Hellman U, Schwartz AL, Ciechanover A. The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminal residue. The Journal of Biological Chemistry. 279: 41414-21. PMID 15254040 DOI: 10.1074/Jbc.M407201200 |
0.489 |
|
| 2004 |
Ciechanover A, Iwai K. The ubiquitin system: from basic mechanisms to the patient bed. Iubmb Life. 56: 193-201. PMID 15230346 DOI: 10.1080/1521654042000223616 |
0.544 |
|
| 2004 |
Lahav-Baratz S, Ben-Izhak O, Sabo E, Ben-Eliezer S, Lavie O, Ishai D, Ciechanover A, Dirnfeld M. Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium. Molecular Human Reproduction. 10: 567-72. PMID 15220466 DOI: 10.1093/Molehr/Gah084 |
0.313 |
|
| 2004 |
Trausch-Azar JS, Lingbeck J, Ciechanover A, Schwartz AL. Ubiquitin-Proteasome-mediated degradation of Id1 is modulated by MyoD. The Journal of Biological Chemistry. 279: 32614-9. PMID 15163661 DOI: 10.1074/Jbc.M403794200 |
0.407 |
|
| 2004 |
Sun XM, Butterworth M, MacFarlane M, Dubiel W, Ciechanover A, Cohen GM. Caspase activation inhibits proteasome function during apoptosis. Molecular Cell. 14: 81-93. PMID 15068805 DOI: 10.1016/S1097-2765(04)00156-X |
0.41 |
|
| 2004 |
Finley D, Ciechanover A, Varshavsky A. Ubiquitin as a central cellular regulator. Cell. 116: S29-32, 2 p followin. PMID 15055578 DOI: 10.1016/S0092-8674(03)00971-1 |
0.414 |
|
| 2004 |
Ciechanover A, Ben-Saadon R. N-terminal ubiquitination: more protein substrates join in. Trends in Cell Biology. 14: 103-6. PMID 15055197 DOI: 10.1016/J.Tcb.2004.01.004 |
0.512 |
|
| 2004 |
Fajerman I, Schwartz AL, Ciechanover A. Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. Biochemical and Biophysical Research Communications. 314: 505-12. PMID 14733935 DOI: 10.1016/J.Bbrc.2003.12.116 |
0.52 |
|
| 2004 |
Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovascular Research. 61: 11-21. PMID 14732197 DOI: 10.1016/J.Cardiores.2003.09.033 |
0.487 |
|
| 2004 |
Amir RE, Haecker H, Karin M, Ciechanover A. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase. Oncogene. 23: 2540-7. PMID 14676825 DOI: 10.1038/Sj.Onc.1207366 |
0.386 |
|
| 2004 |
Cohen S, Achbert-Weiner H, Ciechanover A. Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing. Molecular and Cellular Biology. 24: 475-86. PMID 14673179 DOI: 10.1128/Mcb.24.1.475-486.2004 |
0.348 |
|
| 2003 |
Ciechanover A, Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron. 40: 427-46. PMID 14556719 DOI: 10.1016/S0896-6273(03)00606-8 |
0.474 |
|
| 2003 |
Linares LK, Hengstermann A, Ciechanover A, Müller S, Scheffner M. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proceedings of the National Academy of Sciences of the United States of America. 100: 12009-14. PMID 14507994 DOI: 10.1073/Pnas.2030930100 |
0.415 |
|
| 2003 |
Hermann J, Gulati R, Napoli C, Woodrum JE, Lerman LO, Rodriguez-Porcel M, Sica V, Simari RD, Ciechanover A, Lerman A. Oxidative stress-related increase in ubiquitination in early coronary atherogenesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1730-2. PMID 12958191 DOI: 10.1096/Fj.02-0841Fje |
0.313 |
|
| 2003 |
Ciechanover A. The ubiquitin proteolytic system and pathogenesis of human diseases: A novel platform for mechanism-based drug targeting Biochemical Society Transactions. 31: 474-481. PMID 12653666 DOI: 10.1042/Bst0310474 |
0.512 |
|
| 2003 |
Nadav E, Shmueli A, Barr H, Gonen H, Ciechanover A, Reiss Y. A novel mammalian endoplasmic reticulum ubiquitin ligase homologous to the yeast Hrd1. Biochemical and Biophysical Research Communications. 303: 91-7. PMID 12646171 DOI: 10.1016/S0006-291X(03)00279-1 |
0.472 |
|
| 2003 |
Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL. Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD. The Journal of Biological Chemistry. 278: 1817-23. PMID 12397066 DOI: 10.1074/Jbc.M208815200 |
0.444 |
|
| 2003 |
Kornitzer D, Ciechanover A. Proteasome/Ubiquitination Handbook of Cell Signaling. 3: 129-133. DOI: 10.1016/B978-012124546-7/50652-5 |
0.345 |
|
| 2002 |
Ryoo HD, Bergmann A, Gonen H, Ciechanover A, Steller H. Regulation of Drosophila IAP1 degradation and apoptosis by reaper and ubcD1. Nature Cell Biology. 4: 432-8. PMID 12021769 DOI: 10.1038/Ncb795 |
0.463 |
|
| 2002 |
Amir RE, Iwai K, Ciechanover A. The NEDD8 pathway is essential for SCF(beta -TrCP)-mediated ubiquitination and processing of the NF-kappa B precursor p105. The Journal of Biological Chemistry. 277: 23253-9. PMID 11953428 DOI: 10.1074/Jbc.M200967200 |
0.364 |
|
| 2002 |
Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiological Reviews. 82: 373-428. PMID 11917093 DOI: 10.1152/Physrev.00027.2001 |
0.529 |
|
| 2002 |
Ciechanover A, Schwartz AL. Ubiquitin-mediated degradation of cellular proteins in health and disease. Hepatology (Baltimore, Md.). 35: 3-6. PMID 11786953 DOI: 10.1053/Jhep.2002.30316 |
0.407 |
|
| 2001 |
Amir R, Ciechanover A, Cohen S. The ubiquitin-proteasome system: the relationship between protein degradation and human diseases Harefuah. 140: 1172-1176, 1229. PMID 11789303 |
0.395 |
|
| 2001 |
Ciechanover A. Linking ubiquitin, parkin and synphilin-1 Nature Medicine. 7: 1108-1109. PMID 11590431 DOI: 10.1038/Nm1001-1108 |
0.417 |
|
| 2001 |
Sionov RV, Coen S, Goldberg Z, Berger M, Bercovich B, Ben-Neriah Y, Ciechanover A, Haupt Y. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Molecular and Cellular Biology. 21: 5869-78. PMID 11486026 DOI: 10.1128/Mcb.21.17.5869-5878.2001 |
0.355 |
|
| 2001 |
Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E, Ciechanover A, Israël A. Functional Interaction between SEL-10, an F-box Protein, and the Nuclear Form of Activated Notch1 Receptor Journal of Biological Chemistry. 276: 34371-34378. PMID 11425854 DOI: 10.1074/Jbc.M101343200 |
0.415 |
|
| 2001 |
Ciechanover A. Ubiquitin-mediated degradation of cellular proteins: Why destruction is essential for construction, and how it got from the test tube to the patient's bed Israel Medical Association Journal. 3: 319-327. PMID 11411194 |
0.446 |
|
| 2001 |
Cohen S, Orian A, Ciechanover A. Processing of p105 Is Inhibited by Docking of p50 Active Subunits to the Ankyrin Repeat Domain, and Inhibition Is Alleviated by Signaling via the Carboxyl-terminal Phosphorylation/Ubiquitin-Ligase Binding Domain Journal of Biological Chemistry. 276: 26769-26776. PMID 11350967 DOI: 10.1074/Jbc.M102448200 |
0.403 |
|
| 2001 |
Floyd ZE, Trausch-Azar JS, Reinstein E, Ciechanover A, Schwartz AL. The Nuclear Ubiquitin-Proteasome System Degrades MyoD Journal of Biological Chemistry. 276: 22468-22475. PMID 11309375 DOI: 10.1074/Jbc.M009388200 |
0.516 |
|
| 2001 |
Ciechanover A, Gonen H, Bercovich B, Cohen S, Fajerman I, Israël A, Mercurio F, Kahana C, Schwartz AL, Iwai K, Orian A. Mechanisms of ubiquitin-mediated, limited processing of the NF-κB1 precursor protein p105 Biochimie. 83: 341-349. PMID 11295495 DOI: 10.1016/S0300-9084(01)01239-1 |
0.433 |
|
| 2001 |
Hengstermann A, Linares LK, Ciechanover A, Whitaker NJ, Scheffner M. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 98: 1218-23. PMID 11158620 DOI: 10.1073/Pnas.98.3.1218 |
0.34 |
|
| 2000 |
Reinstein E, Scheffner M, Oren M, Ciechanover A, Schwartz A. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: Targeting via ubiquitination of the N-terminal residue Oncogene. 19: 5944-5950. PMID 11127826 DOI: 10.1038/Sj.Onc.1203989 |
0.49 |
|
| 2000 |
Hershko A, Ciechanover A, Varshavsky A. Basic Medical Research Award. The ubiquitin system. Nature Medicine. 6: 1073-81. PMID 11017125 DOI: 10.1038/80384 |
0.515 |
|
| 2000 |
Orian A, Gonen H, Bercovich B, Fajerman I, Eytan E, Israël A, Mercurio F, Iwai K, Schwartz AL, Ciechanover A. SCF(β-TrCP) ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase Embo Journal. 19: 2580-2591. PMID 10835356 DOI: 10.1093/Emboj/19.11.2580 |
0.345 |
|
| 2000 |
Aviel S, Winberg G, Massucci M, Ciechanover A. Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway: Targeting via ubiquitination of the N-terminal residue Journal of Biological Chemistry. 275: 23491-23499. PMID 10807912 DOI: 10.1074/Jbc.M002052200 |
0.502 |
|
| 2000 |
Ciechanover A, Orian A, Schwartz AL. Ubiquitin-mediated proteolysis: Biological regulation via destruction Bioessays. 22: 442-451. PMID 10797484 DOI: 10.1002/(Sici)1521-1878(200005)22:5<442::Aid-Bies6>3.0.Co;2-Q |
0.528 |
|
| 2000 |
Ciechanover A, Orian A, Schwartz AL. The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications Journal of Cellular Biochemistry. 77: 40-51. PMID 10762014 DOI: 10.1002/(Sici)1097-4644(2000)77:34+<40::Aid-Jcb9>3.0.Co;2-6 |
0.547 |
|
| 2000 |
Kornitzer D, Ciechanover A. Modes of regulation of ubiquitin-mediated protein degradation Journal of Cellular Physiology. 182: 1-11. PMID 10567911 DOI: 10.1002/(Sici)1097-4652(200001)182:1<1::Aid-Jcp1>3.0.Co;2-V |
0.501 |
|
| 1999 |
Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 Molecular Cell. 4: 1029-1040. PMID 10635327 DOI: 10.1016/S1097-2765(00)80231-2 |
0.388 |
|
| 1999 |
Cummings CJ, Reinstein E, Sun Y, Antalffy B, Jiang Y, Ciechanover A, Orr HT, Beaudet AL, Zoghbi HY. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron. 24: 879-92. PMID 10624951 DOI: 10.1016/S0896-6273(00)81035-1 |
0.383 |
|
| 1999 |
Ciechanover A, Breitschopf K, Abu Hatoum O, Bengal E. Degradation of MyoD by the ubiquitin pathway: Regulation by specific DNA-binding and identification of a novel site for ubiquitination Molecular Biology Reports. 26: 59-64. PMID 10363648 DOI: 10.1023/A:1006964122190 |
0.497 |
|
| 1999 |
Gonen H, Bercovich B, Orian A, Carrano A, Takizawa C, Yamanaka K, Pagano M, Iwai K, Ciechanover A. Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IκBα Journal of Biological Chemistry. 274: 14823-14830. PMID 10329681 DOI: 10.1074/Jbc.274.21.14823 |
0.42 |
|
| 1999 |
Orian A, Schwartz AL, Israël A, Whiteside S, Kahana C, Ciechanover A. Structural motifs involved in ubiquitin-mediated processing of the NF- κB precursor p105: Roles of the Glycine-rich region and a downstream ubiquitination domain Molecular and Cellular Biology. 19: 3664-3673. PMID 10207090 DOI: 10.1128/Mcb.19.5.3664 |
0.433 |
|
| 1999 |
Schwartz AL, Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases Annual Review of Medicine. 50: 57-74. PMID 10073263 DOI: 10.1146/Annurev.Med.50.1.57 |
0.451 |
|
| 1998 |
Ciechanover A. The ubiquitin-proteasome pathway: On protein death and cell life Embo Journal. 17: 7151-7160. PMID 9857172 DOI: 10.1093/Emboj/17.24.7151 |
0.512 |
|
| 1998 |
Breitschopf K, Bengal E, Ziv T, Admon A, Ciechanover A. A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. The Embo Journal. 17: 5964-73. PMID 9774340 DOI: 10.1093/Emboj/17.20.5964 |
0.509 |
|
| 1998 |
Hershko A, Ciechanover A. The ubiquitin system. Annual Review of Biochemistry. 67: 425-79. PMID 9759494 DOI: 10.1146/Annurev.Biochem.67.1.425 |
0.699 |
|
| 1998 |
Hatoum OA, Gross-Mesilaty S, Breitschopf K, Hoffman A, Gonen H, Ciechanover A, Bengal E. Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: Regulation by specific DNA binding Molecular and Cellular Biology. 18: 5670-5677. PMID 9742084 DOI: 10.1128/Mcb.18.10.5670 |
0.478 |
|
| 1998 |
Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias KE, Schwartz AL, Kahana C, Ciechanover A. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway Proceedings of the National Academy of Sciences of the United States of America. 95: 8058-8063. PMID 9653139 DOI: 10.1073/Pnas.95.14.8058 |
0.455 |
|
| 1998 |
Ciechanover A, Schwartz AL. The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death Proceedings of the National Academy of Sciences of the United States of America. 95: 2727-2730. PMID 9501156 DOI: 10.1073/Pnas.95.6.2727 |
0.486 |
|
| 1998 |
Sancho E, Vilá MR, Sánchez-Pulido L, Lozano JJ, Paciucci R, Nadal M, Fox M, Harvey C, Bercovich B, Loukili N, Ciechanover A, Lin SL, Sanz F, Estivill X, Valencia A, et al. Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells Molecular and Cellular Biology. 18: 576-589. PMID 9418904 DOI: 10.1128/Mcb.18.1.576 |
0.464 |
|
| 1997 |
Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1 Proceedings of the National Academy of Sciences of the United States of America. 94: 12616-12621. PMID 9356498 DOI: 10.1073/Pnas.94.23.12616 |
0.421 |
|
| 1997 |
Yaron A, Gonen H, Alkalay I, Hatzubai A, Jung S, Beyth S, Mercurio F, Manning AM, Ciechanover A, Ben-Neriah Y. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. The Embo Journal. 16: 6486-94. PMID 9351830 DOI: 10.1093/Emboj/16.21.6486 |
0.343 |
|
| 1997 |
Staub O, Gautschi I, Ishikawa T, Breitschopf K, Ciechanover A, Schild L, Rotin D. Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination Embo Journal. 16: 6325-6336. PMID 9351815 DOI: 10.1093/Emboj/16.21.6325 |
0.34 |
|
| 1997 |
Ciechanover A, Hargrove JL, Gross-Mesilaty S. Ubiquitin-mediated degradation of tyrosine aminotransferase (TAT) in vitro and in vivo Molecular Biology Reports. 24: 27-33. PMID 9228277 DOI: 10.1023/A:1006896321905 |
0.538 |
|
| 1997 |
Gonen H, Shkedy D, Barnoy S, Kosower NS, Ciechanover A. On the involvement of calpains in the degradation of the tumor suppressor protein p53 Febs Letters. 406: 17-22. PMID 9109377 DOI: 10.1016/S0014-5793(97)00225-1 |
0.444 |
|
| 1997 |
Stephen AG, Trausch-Azar JS, Handley-Gearhart PM, Ciechanover A, Schwartz AL. Identification of a region within the ubiquitin-activating enzyme required for nuclear targeting and phosphorylation Journal of Biological Chemistry. 272: 10895-10903. PMID 9099746 DOI: 10.1074/Jbc.272.16.10895 |
0.364 |
|
| 1997 |
Gross-Mesilaty S, Hargrove JL, Ciechanover A. Degradation of tyrosine aminotransferase (TAT) via the ubiquitin-proteasome pathway Febs Letters. 405: 175-180. PMID 9089286 DOI: 10.1016/S0014-5793(97)00181-6 |
0.481 |
|
| 1997 |
Bercovich B, Stancovski I, Mayer A, Blumenfeld N, Laszlo A, Schwartz AL, Ciechanover A. Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70 Journal of Biological Chemistry. 272: 9002-9010. PMID 9083024 DOI: 10.1074/Jbc.272.14.9002 |
0.542 |
|
| 1997 |
Levitskaya J, Sharipo A, Ciechanover A, Masucci MG. Inhibition of ubiquitin-proteasome dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus (EBV) nuclear antigen (EBNA)-1 Immunology Letters. 56: 438. DOI: 10.1016/S0165-2478(97)86779-X |
0.396 |
|
| 1996 |
Wöstmann C, Liakopoulos D, Ciechanover A, Bakker-Grunwald T. Characterization of ubiquitin genes and -transcripts and demonstration of a ubiquitin-conjugating system in Entamoeba histolytica Molecular and Biochemical Parasitology. 82: 81-90. PMID 8943152 DOI: 10.1016/0166-6851(96)02725-9 |
0.371 |
|
| 1996 |
Ciechanover A. Ubiquitin-mediated proteolysis and male sterility Nature Medicine. 2: 1188-1190. PMID 8898739 DOI: 10.1038/Nm1196-1188 |
0.4 |
|
| 1996 |
Gonen H, Dickman D, Schwartz AL, Ciechanover A. Protein synthesis elongation factor EF-1α is an isopeptidase essential for ubiquitin-dependent degradation of certain proteolytic substrates Advances in Experimental Medicine and Biology. 389: 209-219. PMID 8861013 DOI: 10.1007/978-1-4613-0335-0_26 |
0.492 |
|
| 1996 |
Strous GJ, Van Kerkhof P, Govers R, Ciechanover A, Schwartz AL. The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor Embo Journal. 15: 3806-3812. PMID 8670885 DOI: 10.1002/J.1460-2075.1996.Tb00754.X |
0.402 |
|
| 1996 |
Stephen AG, Trausch-Azar JS, Ciechanover A, Schwartz AL. The ubiquitin-activating enzyme E1 is phosphorylated and localized to the nucleus in a cell cycle-dependent manner Journal of Biological Chemistry. 271: 15608-15614. PMID 8663123 DOI: 10.1074/Jbc.271.26.15608 |
0.418 |
|
| 1996 |
Gronen H, Stancovski I, Shkedy D, Hadari T, Bercovich B, Bengal E, Mesilati S, Abu-Hatoum O, Schwartz AL, Ciechanover A. Isolation, characterization, and partial purification of a novel ubiquitin-protein ligase, E3: Taegeting of protein substrates via multiple and distinct recognition signals and conjugating enzymes Journal of Biological Chemistry. 271: 302-310. PMID 8550577 DOI: 10.1074/Jbc.271.1.302 |
0.499 |
|
| 1995 |
Ciechanover A, Laszlo A, Bercovich B, Stancovski I, Alkalay I, Ben-Neriah Y, Orian A. The ubiquitin-mediated proteolytic system: involvement of molecular chaperones, degradation of oncoproteins, and activation of transcriptional regulators. Cold Spring Harbor Symposia On Quantitative Biology. 60: 491-501. PMID 8824422 DOI: 10.1101/Sqb.1995.060.01.053 |
0.418 |
|
| 1995 |
Stancovski I, Gonen H, Orian A, Schwartz AL, Ciechanover A. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: Identification and characterization of the conjugating enzymes Molecular and Cellular Biology. 15: 7106-7116. PMID 8524278 DOI: 10.1128/Mcb.15.12.7106 |
0.499 |
|
| 1995 |
Elias S, Bercovich B, Kahana C, Coffino P, Fischer M, Hilt W, Wolf DH, Ciechanover A. Degradation of ornithine decarboxylase by the mammalian and yeast 26S proteasome complexes requires all the components of the protease European Journal of Biochemistry. 229: 276-283. PMID 7744041 DOI: 10.1111/J.1432-1033.1995.0276L.X |
0.511 |
|
| 1995 |
Orian A, Whiteside S, Israël A, Stancovski I, Schwartz AL, Ciechanover A. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105: Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation Journal of Biological Chemistry. 270: 21707-21714. PMID 7665588 DOI: 10.1074/Jbc.270.37.21707 |
0.474 |
|
| 1995 |
Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America. 92: 10599-603. PMID 7479848 DOI: 10.1073/Pnas.92.23.10599 |
0.337 |
|
| 1994 |
Ciechanover A. The ubiquitin-mediated proteolytic pathway. Brain Pathology (Zurich, Switzerland). 3: 67-75. PMID 8269085 DOI: 10.1111/J.1750-3639.1993.Tb00727.X |
0.552 |
|
| 1994 |
Ciechanover A, Shkedy D, Oren M, Bercovich B. Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2 Journal of Biological Chemistry. 269: 9582-9589. PMID 8144545 |
0.354 |
|
| 1994 |
Blumenfeld N, Gonen H, Mayer A, Smith CE, Siegel NR, Schwartz AL, Ciechanover A. Purification and characterization of a novel species of ubiquitin-carrier protein, E2, that is involved in degradation of non-"N-end rule" protein substrates Journal of Biological Chemistry. 269: 9574-9581. PMID 8144544 |
0.38 |
|
| 1994 |
Ciechanover A, Schwartz AL. The ubiquitin-mediated proteolytic pathway: Mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins Faseb Journal. 8: 182-191. PMID 8119489 DOI: 10.1096/Fasebj.8.2.8119489 |
0.562 |
|
| 1994 |
Gonen H, Smith CE, Siegel NR, Kahana C, Merrick WC, Chakraburtty K, Schwartz AL, Ciechanover A. Protein synthesis elongation factor EF-1α is essential for ubiquitin-dependent degradation of certain Nα-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu Proceedings of the National Academy of Sciences of the United States of America. 91: 7648-7652. PMID 8052636 DOI: 10.1073/Pnas.91.16.7648 |
0.456 |
|
| 1994 |
Shkedy D, Gonen H, Bercovich B, Ciechanover A. Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system Febs Letters. 348: 126-130. PMID 8034027 DOI: 10.1016/0014-5793(94)00582-6 |
0.513 |
|
| 1994 |
Grenfell SJ, Trausch-Azar JS, Handley-Gearhart PM, Ciechanover A, Schwartz AL. Nuclear localization of the ubiquitin-activating enzyme, E1, is cell-cycle-dependent Biochemical Journal. 300: 701-708. PMID 8010951 DOI: 10.1042/Bj3000701 |
0.417 |
|
| 1994 |
Fischer M, Hilt W, Richter-Ruoff B, Gonen H, Ciechanover A, Wolf DH. The 26S proteasome of the yeast Saccharomyces cerevisiae Febs Letters. 355: 69-75. PMID 7957966 DOI: 10.1016/0014-5793(94)01177-X |
0.46 |
|
| 1994 |
Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell. 79: 13-21. PMID 7923371 DOI: 10.1016/0092-8674(94)90396-4 |
0.519 |
|
| 1994 |
Ciechanover A. The Ubiquitin-Mediated Proteolytic Pathway: Mechanisms of Action and Cellular Physiology Biological Chemistry Hoppe-Seyler. 375: 565-582. PMID 7840898 DOI: 10.1515/bchm3.1994.375.9.565 |
0.472 |
|
| 1994 |
Handley-Gearhart PM, Trausch-Azar JS, Ciechanover A, Schwartz AL. Rescue of the complex temperature-sensitive phenotype of Chinese hamster ovary E36ts20 cells by expression of the human ubiquitin-activating enzyme cDNA Biochemical Journal. 304: 1015-1020. PMID 7818464 DOI: 10.1042/Bj3041015 |
0.42 |
|
| 1993 |
Trausch JS, Grenfell SJ, Handley-Gearhart PM, Ciechanover A, Schwartz AL. Immunofluorescent localization of the ubiquitin-activating enzyme, E1, to the nucleus and cytoskeleton American Journal of Physiology - Cell Physiology. 264: C93-C102. PMID 8430776 DOI: 10.1152/Ajpcell.1993.264.1.C93 |
0.386 |
|
| 1992 |
Ciechanover A. The ubiquitin-mediated system for intracellular protein degradation. Journal of Basic and Clinical Physiology and Pharmacology. 2: 141-59. PMID 1665707 DOI: 10.1515/Jbcpp.1991.2.3.141 |
0.546 |
|
| 1992 |
Schwartz AL, Trausch JS, Ciechanover A, Slot JW, Geuze H. Immunoelectron microscopic localization of the ubiquitin-activating enzyme E1 in HepG2 cells Proceedings of the National Academy of Sciences of the United States of America. 89: 5542-5546. PMID 1376922 DOI: 10.1073/Pnas.89.12.5542 |
0.397 |
|
| 1992 |
Schwartz AL, Ciechanover A. Ubiquitin-mediated protein modification and degradation American Journal of Respiratory Cell and Molecular Biology. 7: 463-468. PMID 1329865 DOI: 10.1165/Ajrcmb/7.5.463 |
0.51 |
|
| 1992 |
Hershko A, Ciechanover A. The ubiquitin system for protein degradation. Annual Review of Biochemistry. 61: 761-807. PMID 1323239 DOI: 10.1146/Annurev.Bi.61.070192.003553 |
0.685 |
|
| 1992 |
Lenk SE, Dunn WA, Trausch JS, Ciechanover A, Schwartz AL. Ubiquitin-activating enzyme, E1, is associated with maturation of autophagic vacuoles Journal of Cell Biology. 118: 301-308. PMID 1321157 DOI: 10.1083/Jcb.118.2.301 |
0.467 |
|
| 1992 |
Schwartz AL, Brandt RA, Geuze H, Ciechanover A. Stress-induced alterations in autophagic pathway: Relationship to ubiquitin system American Journal of Physiology - Cell Physiology. 262: C1031-C1038. PMID 1314483 DOI: 10.1152/Ajpcell.1992.262.4.C1031 |
0.424 |
|
| 1991 |
Handley PM, Mueckler M, Siegel NR, Ciechanover A, Schwartz AL. Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. Proceedings of the National Academy of Sciences of the United States of America. 88: 258-62. PMID 1986373 DOI: 10.1073/Pnas.88.1.258 |
0.405 |
|
| 1991 |
DeMartino GN, McCullough ML, Reckelhoff JF, Croall DE, Ciechanover A, McGuire MJ. ATP-stimulated degradation of endogenous proteins in cell-free extracts of BHK 21/C13 fibroblasts. A key role for the proteinase, macropain, in the ubiquitin-dependent degradation of short-lived proteins. Biochimica Et Biophysica Acta. 1073: 299-308. PMID 1849005 DOI: 10.1016/0304-4165(91)90135-4 |
0.342 |
|
| 1991 |
Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL, Brodeur GM. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proceedings of the National Academy of Sciences of the United States of America. 88: 139-43. PMID 1846034 DOI: 10.1073/Pnas.88.1.139 |
0.554 |
|
| 1991 |
Handley PM, Mueckler M, Siegel NR, Ciechanover A, Schwartz AL. Corrections: Molecular Cloning, Sequence, and Tissue Distribution of the Human Ubiquitin-Activating Enzyme E1 Proceedings of the National Academy of Sciences of the United States of America. 88: 7456. DOI: 10.1073/Pnas.88.16.7456B |
0.307 |
|
| 1990 |
Rosenberg-Hasson Y, Bercovich Z, Ciechanover A, Kahana C. Degradation of ornithine decarboxylase in mammalian cells is ATP dependent but ubiquitin independent. European Journal of Biochemistry. 185: 469-74. PMID 2555193 DOI: 10.1111/J.1432-1033.1989.Tb15138.X |
0.477 |
|
| 1989 |
Ciechanover A, Schwartz AL. How are substrates recognized by the ubiquitin-mediated proteolytic system Trends in Biochemical Sciences. 14: 483-488. PMID 2696178 DOI: 10.1016/0968-0004(89)90180-1 |
0.447 |
|
| 1989 |
Mayer A, Siegel NR, Schwartz AL, Ciechanover A. Degradation of proteins with acetylated amino termini by the ubiquitin system Science. 244: 1480-1483. PMID 2544030 DOI: 10.1126/Science.2544030 |
0.508 |
|
| 1988 |
Ciechanover A, Ferber S, Ganoth D, Elias S, Hershko A, Arfin S. Purification and characterization of arginyl-tRNA-protein transferase from rabbit reticulocytes. Its involvement in post-translational modification and degradation of acidic NH2 termini substrates of the ubiquitin pathway. The Journal of Biological Chemistry. 263: 11155-67. PMID 2841321 |
0.67 |
|
| 1988 |
Schwartz AL, Ciechanover A, Brandt RA, Geuze HJ. Immunoelectron microscopic localization of ubiquitin in hepatoma cells. The Embo Journal. 7: 2961-2966. DOI: 10.1002/J.1460-2075.1988.Tb03158.X |
0.436 |
|
| 1987 |
Ciechanover A. Regulation of the ubiquitin-mediated proteolytic pathway: role of the substrate alpha-NH2 group and of transfer RNA. Journal of Cellular Biochemistry. 34: 81-100. PMID 3036896 DOI: 10.1002/Jcb.240340203 |
0.545 |
|
| 1987 |
Ferber S, Ciechanover A. Role of arginine-tRNA in protein degradation by the ubiquitin pathway. Nature. 326: 808-11. PMID 3033511 DOI: 10.1038/326808A0 |
0.525 |
|
| 1986 |
Hershko A, Ciechanover A. The ubiquitin pathway for the degradation of intracellular proteins. Progress in Nucleic Acid Research and Molecular Biology. 33: 19-56, 301. PMID 3025922 DOI: 10.1016/S0079-6603(08)60019-7 |
0.697 |
|
| 1986 |
TEETERS CL, LODISH HF, CIECHANOVER A, WALLACE BA. Transferrin and Apotransferrin: pH-dependent Conformational Changes Associated with Receptor-mediated Uptake Annals of the New York Academy of Sciences. 463: 403-407. DOI: 10.1111/J.1749-6632.1986.Tb21608.X |
0.421 |
|
| 1985 |
Patel VP, Ciechanover A, Platt O, Lodish HF. Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes. Proceedings of the National Academy of Sciences of the United States of America. 82: 440-4. PMID 3855563 DOI: 10.1073/Pnas.82.2.440 |
0.471 |
|
| 1985 |
Neutra MR, Ciechanover A, Owen LS, Lodish HF. Intracellular transport of transferrin- and asialoorosomucoid-colloidal gold conjugates to lysosomes after receptor-mediated endocytosis. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 33: 1134-44. PMID 2997327 DOI: 10.1177/33.11.2997327 |
0.493 |
|
| 1985 |
Ciechanover A, Wolin SL, Steitz JA, Lodish HF. Transfer RNA is an essential component of the ubiquitin- and ATP-dependent proteolytic system. Proceedings of the National Academy of Sciences of the United States of America. 82: 1341-5. PMID 2983338 DOI: 10.1073/Pnas.82.5.1341 |
0.582 |
|
| 1984 |
Ciechanover A, Finley D, Varshavsky A. The ubiquitin-mediated proteolytic pathway and mechanisms of energy-dependent intracellular protein degradation. Journal of Cellular Biochemistry. 24: 27-53. PMID 6327743 DOI: 10.1002/Jcb.240240104 |
0.452 |
|
| 1984 |
Ciechanover A, Finley D, Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell. 37: 57-66. PMID 6327060 DOI: 10.1016/0092-8674(84)90300-3 |
0.451 |
|
| 1984 |
Finley D, Ciechanover A, Varshavsky A. Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85. Cell. 37: 43-55. PMID 6327059 DOI: 10.1016/0092-8674(84)90299-X |
0.498 |
|
| 1983 |
Ciechanover A, Schwartz AL, Lodish HF. Sorting and recycling of cell surface receptors and endocytosed ligands: The asialoglycoprotein and transferrin receptors Journal of Cellular Biochemistry. 23: 107-130. PMID 6327736 DOI: 10.1002/Jcb.240230111 |
0.448 |
|
| 1983 |
Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. The Journal of Biological Chemistry. 258: 8206-14. PMID 6305978 |
0.607 |
|
| 1983 |
Dautry-Varsat A, Ciechanover A, Lodish HF. pH and the recycling of transferrin during receptor-mediated endocytosis. Proceedings of the National Academy of Sciences of the United States of America. 80: 2258-62. PMID 6300903 DOI: 10.1073/Pnas.80.8.2258 |
0.437 |
|
| 1983 |
Ciechanover A, Schwartz AL, Lodish HF. The asialoglycoprotein receptor internalizes and recycles independently of the transferrin and insulin receptors. Cell. 32: 267-75. PMID 6297785 DOI: 10.1016/0092-8674(83)90517-2 |
0.43 |
|
| 1982 |
Hershko A, Eytan E, Ciechanover A, Haas AL. Immunochemical analysis of the turnover of ubiquitin-protein conjugates in intact cells. Relationship to the breakdown of abnormal proteins. The Journal of Biological Chemistry. 257: 13964-70. PMID 6292216 |
0.743 |
|
| 1982 |
Hershko A, Ciechanover A. Mechanisms of intracellular protein breakdown. Annual Review of Biochemistry. 51: 335-64. PMID 6287917 DOI: 10.1146/Annurev.Bi.51.070182.002003 |
0.669 |
|
| 1982 |
Ciechanover A, Elias S, Heller H, Hershko A. "Covalent affinity" purification of ubiquitin-activating enzyme. The Journal of Biological Chemistry. 257: 2537-42. PMID 6277904 |
0.558 |
|
| 1981 |
Ciechanover A, Heller H, Katz-Etzion R, Hershko A. Activation of the heat-stable polypeptide of the ATP-dependent proteolytic system. Proceedings of the National Academy of Sciences of the United States of America. 78: 761-5. PMID 6262770 DOI: 10.1073/Pnas.78.2.761 |
0.61 |
|
| 1981 |
Hershko A, Ciechanover A, Rose IA. Identification of the active amino acid residue of the polypeptide of ATP-dependent protein breakdown. The Journal of Biological Chemistry. 256: 1525-8. PMID 6257674 |
0.671 |
|
| 1980 |
Hershko A, Ciechanover A, Heller H, Haas AL, Rose IA. Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis. Proceedings of the National Academy of Sciences of the United States of America. 77: 1783-6. PMID 6990414 DOI: 10.1073/Pnas.77.4.1783 |
0.779 |
|
| 1980 |
Ciechanover A, Heller H, Elias S, Haas AL, Hershko A. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proceedings of the National Academy of Sciences of the United States of America. 77: 1365-8. PMID 6769112 DOI: 10.1073/Pnas.77.3.1365 |
0.732 |
|
| 1980 |
Ciechanover A, Elias S, Heller H, Ferber S, Hershko A. Characterization of the heat-stable polypeptide of the ATP-dependent proteolytic system from reticulocytes. The Journal of Biological Chemistry. 255: 7525-8. PMID 6249802 |
0.56 |
|
| 1979 |
Hershko A, Ciechanover A, Rose IA. Resolution of the ATP-dependent proteolytic system from reticulocytes: a component that interacts with ATP. Proceedings of the National Academy of Sciences of the United States of America. 76: 3107-10. PMID 290989 DOI: 10.1073/Pnas.76.7.3107 |
0.695 |
|
| 1976 |
Ciechanover A, Hershko A. Early effects of serum on phospholipid metabolism in untransformed and oncogenic virus-transformed cultured fibroblasts. Biochemical and Biophysical Research Communications. 73: 85-91. PMID 187191 DOI: 10.1016/0006-291X(76)90500-3 |
0.525 |
|
| Show low-probability matches. |
